GGrantIndex
Sort

46,585 grants matching heart failure

Understanding Ciliary Functions in Mammalian Development

$591,040
Jeremy F Reiter · University Of California, San Francisco · R01 · FY2020 · HD

Understanding Ciliary Functions in Mammalian Development

$591,040
Jeremy F Reiter · University Of California, San Francisco · R01 · FY2019 · HD

Splanchnic Nerve Modulation In Heart Failure (Splanchnic X)

$590,884
Marat Fudim · Duke University · R01 · FY2025 · HL

Advancing Symptom Science and Management in Cystic Fibrosis: Biological, Social, and Clinical Mechanisms

$590,820
Dionysios Kavalieratos · Emory University · R01 · FY2024 · HL

Molecular and Cellular Basis of Cardiovascular Disease

$590,818
Brian L Black · University Of California, San Francisco · T32 · FY2018 · HL

Pittsburgh Center for Kidney Research

$590,769
Thomas R. Kleyman · University Of Pittsburgh At Pittsburgh · P30 · FY2022 · DK

Pittsburgh Center for Kidney Research

$590,769
Thomas R. Kleyman · University Of Pittsburgh At Pittsburgh · P30 · FY2020 · DK

Pittsburgh Center for Kidney Research

$590,769
Thomas R. Kleyman · University Of Pittsburgh At Pittsburgh · P30 · FY2019 · DK

Pittsburgh Center for Kidney Research

$590,769
Thomas R. Kleyman · University Of Pittsburgh At Pittsburgh · P30 · FY2021 · DK

Community-Based Strategies to Reduce Cardiometabolic Disease in the Deep South

$590,754
Monica L. Baskin · University Of Alabama At Birmingham · P50 · FY2024 · MD

Metabolic Impact and Mechanism of Enhanced Mitochondrial Calcium Uptake in Mitochondrial Cardiomyopathies

$590,741
Dipayan Chaudhuri · Utah State Higher Education System--University Of Utah · R01 · FY2025 · HL

Improving outcomes from cardiac rehabilitation among older adults through exercise testing and individualized exercise intensity prescriptions

$590,737
Quinn Russell Pack · Baystate Medical Center, Inc. · R01 · FY2023 · AG

IGF::OT::IGF RD CORONERY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) FIELD

$590,733
Cora E Lewis · University Of Alabama At Birmingham · N01 · FY2014 · HL

REHAB-PH Trial: Repurposing a Histamine Antagonist to Benefit Patients with Pulmonary Hypertension

$590,685
Peter J Leary · University Of Washington · R33 · FY2022 · HL

Mechanisms of T cell activation in cardiac fibrosis and non-ischemic heart failure

$590,638
Maria Pilar Alcaide Alonso · Tufts University Boston · R01 · FY2019 · HL

Extracorporeal Circulation Without Anticoagulation

$590,614
Robert H. Bartlett · University Of Michigan At Ann Arbor · R01 · FY2008 · HD

Synergistically Target Mitochondria for Heart Failure Treatment

$590,571
Lufang Zhou · Ohio State University · R01 · FY2025 · HL

An Engineered Human Ductus Arteriosus Capable of Biomimetic Response to Vasoactive Agents

$590,565
Elaine Shelton · Vanderbilt University Medical Center · R01 · FY2025 · HD

Surgery to Prevent Postinfarction Ventricular Remodeling

$590,555
University Of Pennsylvania · R01 · FY2004 · HL

Sex Hormones and Cardiac Arrhythmia in Transgenic LQT2 Rabbits

$590,482
Gideon Koren · Rhode Island Hospital · R01 · FY2010 · HL

Improving Quality by Maintaining Accurate Problem Lists in the EHR (IQ-MAPLE)

$590,477
Adam T Wright · Brigham And Women'S Hospital · R01 · FY2015 · HL

Drug abuse and HIV-associated pulmonary vascular injury

$590,415
Navneet Kaur Dhillon · University Of Kansas Medical Center · R01 · FY2024 · HL

Cardiac Lipotoxicity and Ceramide Metabolism in Heart Failure

$590,391
P. Christian Schulze · Columbia University Health Sciences · R01 · FY2014 · HL

Regulation of cardiac inflammation by fibroblasts

$590,382
Michelle D Tallquist · University Of Hawaii At Manoa · R01 · FY2019 · HL

Identifying Successful Strategies of Specialist Palliative Care Implementation for People with Advanced Heart Failure

$590,371
Shelli Leore Feder · Yale University · R01 · FY2024 · HL